Seeking efficiency in executive compensation benchmarking?

Unlock Efficiency in Executive Compensation Benchmarking with CompAnalyst Executive

CompAnalyst Executive

The charts on this page feature a breakdown of the total annual pay for the top executives at IDEAYA BIOSCIENCES INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. IDEAYA BIOSCIENCES INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. IDEAYA BIOSCIENCES INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Yujiro S. Hata
President and Chief Executive Officer
Total Cash $897,000 Equity $5,083,440 Other $15,000 Total Compensation $5,995,440
Jason S. Throne J.D.
Chief Legal Officer
Total Cash $583,800 Equity $1,270,860 Other $15,000 Total Compensation $1,869,660
Michael A. White Ph.D.
Chief Scientific Officer
Total Cash $646,800 Equity $2,096,919 Other $15,000 Total Compensation $2,758,719
Darrin M. Beaupre MD., Ph.D.
Chief Medical Officer
Total Cash $662,200 Equity $1,143,774 Other $3,377 Total Compensation $1,809,351
Andres Ruiz Briseno
Senior Vice President, Head of Finance and Investor Relations
Total Cash $470,125 Equity $927,417 Other $15,000 Total Compensation $1,412,542
Paul A. Stone
Former Chief Financial Officer
Total Cash $432,024 Equity $1,779,204 Other $14,775 Total Compensation $2,226,003
For its 2023 fiscal year, IDEAYA BIOSCIENCES INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Yujiro S. Hata CEO Pay $5,995,440 Median Employee Pay $251,830 CEO Pay Ratio 24:1
For its 2022 fiscal year, IDEAYA BIOSCIENCES INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Catherine Mackey, Ph.D. Total Cash $224,372
Jeffrey L. Stein, Ph.D. Total Cash $155,453
M. Garret Hampton, Ph.D. Total Cash $141,953
Scott W. Morrison Total Cash $156,953
Susan L. Kelley, M.D. Total Cash $141,953
Terry J. Rosen, Ph.D. Total Cash $142,953
Timothy M. Shannon, M.D. Total Cash $183,453
Wendy L. Yarno Total Cash $150,453

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.